Category: pharma & healthcare

Putting COVID-19 Behind Us: A Research Agenda To Prepare For The Next Pandemic

COVID-19 is neither the first nor the last epidemic our country face — what do we need to do today to prepare for the next one?

How Policymakers Can Win The Corona Virus War

Battling a pandemic requires logistics on a massive scale. … The mission during the “peace” between pandemic battles is one of discovery and invention, where centralized planning can be an impediment.

Will Wearing Gloves Help Protect You From Coronavirus?

Some airports in the U.K. are now handing out gloves to travelers, but will they really help protect you from contracting the COVID-19 coronavirus?

Blood Clotting And COVID-19: How Serious Is It?

Anecdotal evidence suggests SARS-CoV-2 infection can lead to serious blood clots in COVID-19 patients as well as those who are otherwise asymptomatic.

COVID-19 Crowding Out Non-COVID-19 Healthcare And Drug Development

there is an opportunity cost of allocating nearly all available resources on the novel coronavirus. The dollars spent on the coronavirus can’t be used to address other diseases or conditions.

Heart Drugs May Influence Gut Microbiome In Obese People, Says New Study

Could a common heart drug be used to treat a pro-inflammatory gut microbiome?

COVID-19 Testing In Homeless Shelters: Care, Compassion And Combatting Structural Inequalities

Homeless individuals are disproportionately impacted by severe chronic health problems such as heart disease, cancer, substance use disorders and mental illness, as well as infections like COVID-19.

Responsible Reopening: A Lesson From NYU Shanghai

The small university is taking a “try it and see” approach. If infection rates rise again, they are prepared to quickly implement harsher measures to reduce them.

PBM Exclusion Lists: Useful For Leverage But Do They Benefit The Patient?

While net transaction prices of prescription drugs have been stagnant, what matters most to patients, out-of-pocket spending, has increased.

COVID Immunity: How Protected Are You?

If I have antibodies to the COVID-19 virus, or if I recovered from the disease, am I protected? These are the two burning questions workers and employers are asking today.